XML 73 R57.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Stockholders' Equity  
Common Stock Dividends (Table)

For the year ended December 31,

    

2024

    

2023

    

2022

 

Dividends declared per common share

$

2.85

$

2.60

$

2.56

Reconciliation of Outstanding Common Shares (Table)

For the year ended December 31,

 

    

2024

    

2023

    

2022

 

Beginning balance

236,438,294

243,549,782

261,673,076

Shares issued

2,455,503

2,469,841

4,937,910

Treasury stock acquired

(12,668,636)

(9,581,329)

(23,061,204)

Ending balance

226,225,161

236,438,294

243,549,782

Other Comprehensive Income (Loss) (Table)

For the year ended December 31, 2024

    

Pre-Tax

    

Tax

    

After-Tax

 

(in millions)

Net unrealized losses on available-for-sale securities during the period

$

(1,033.4)

$

227.0

$

(806.4)

Reclassification adjustment for losses included in net income (1)

 

138.4

 

(26.2)

 

112.2

Adjustments for assumed changes in amortization patterns

 

9.8

 

(2.1)

 

7.7

Adjustments for assumed changes in policyholder liabilities

 

10.8

 

(2.3)

 

8.5

Net unrealized losses on available-for-sale securities

 

(874.4)

 

196.4

 

(678.0)

Net unrealized gains on derivative instruments during the period

 

71.2

(15.0)

56.2

Reclassification adjustment for gains included in net income (2)

 

(3.5)

0.8

(2.7)

Adjustments for assumed changes in amortization patterns

 

0.5

(0.1)

0.4

Net unrealized gains on derivative instruments

 

68.2

(14.3)

53.9

Liability for future policy benefits discount rate remeasurement gain (3)

1,281.9

(271.9)

1,010.0

Market risk benefit nonperformance risk remeasurement loss (4)

(10.3)

2.2

(8.1)

Foreign currency translation adjustment

(301.5)

4.9

(296.6)

Unrecognized postretirement benefit obligation during the period

 

20.7

(5.1)

15.6

Amortization of amounts included in net periodic benefit cost (6)

 

20.3

(5.2)

15.1

Net unrecognized postretirement benefit obligation

 

41.0

(10.3)

30.7

Other comprehensive income

$

204.9

$

(93.0)

$

111.9

For the year ended December 31, 2023

    

Pre-Tax

    

Tax

    

After-Tax

 

(in millions)

Net unrealized gains on available-for-sale securities during the period

$

1,986.8

$

(419.8)

$

1,567.0

Reclassification adjustment for losses included in net income (1)

 

351.1

 

(73.5)

 

277.6

Adjustments for assumed changes in amortization patterns

 

(2.6)

 

0.6

 

(2.0)

Adjustments for assumed changes in policyholder liabilities

 

0.7

 

(0.2)

 

0.5

Net unrealized gains on available-for-sale securities

 

2,336.0

 

(492.9)

 

1,843.1

Net unrealized losses on derivative instruments during the period

 

(44.9)

9.4

(35.5)

Reclassification adjustment for gains included in net income (2)

 

(7.4)

1.6

(5.8)

Adjustments for assumed changes in amortization patterns

 

(0.9)

0.2

(0.7)

Adjustments for assumed changes in policyholder liabilities

 

0.2

0.2

Net unrealized losses on derivative instruments

 

(53.0)

11.2

(41.8)

Liability for future policy benefits discount rate remeasurement loss (3)

(365.9)

53.2

(312.7)

Market risk benefit nonperformance risk remeasurement loss (4)

(39.2)

8.3

(30.9)

Foreign currency translation adjustment during the period

68.0

5.1

73.1

Reclassification adjustment for losses included in net income (5)

0.6

0.6

Foreign currency translation adjustment

 

68.6

5.1

73.7

Unrecognized postretirement benefit obligation during the period

 

(19.3)

5.2

(14.1)

Amortization of amounts included in net periodic benefit cost (6)

 

22.4

(5.9)

16.5

Net unrecognized postretirement benefit obligation

 

3.1

(0.7)

2.4

Other comprehensive income

$

1,949.6

$

(415.8)

$

1,533.8

For the year ended December 31, 2022

    

Pre-Tax

    

Tax

    

After-Tax

 

(in millions)

Net unrealized losses on available-for-sale securities during the period

$

(13,158.9)

$

2,787.9

$

(10,371.0)

Reclassification adjustment for losses included in net income (1)

 

398.9

 

(87.6)

 

311.3

Adjustments for assumed changes in amortization patterns

 

(3.7)

 

0.7

 

(3.0)

Adjustments for assumed changes in policyholder liabilities

 

273.2

 

(57.3)

 

215.9

Net unrealized losses on available-for-sale securities

 

(12,490.5)

 

2,643.7

 

(9,846.8)

Net unrealized losses on derivative instruments during the period

 

(1.4)

0.3

(1.1)

Reclassification adjustment for gains included in net income (2)

 

(28.0)

5.8

(22.2)

Adjustments for assumed changes in amortization patterns

 

(0.1)

(0.1)

Adjustments for assumed changes in policyholder liabilities

 

0.4

(0.1)

0.3

Net unrealized losses on derivative instruments

 

(29.1)

6.0

(23.1)

Liability for future policy benefits discount rate remeasurement gain (3)

6,030.4

(1,251.9)

4,778.5

Market risk benefit nonperformance risk remeasurement gain (4)

144.3

(30.2)

114.1

Foreign currency translation adjustment

(26.9)

4.8

(22.1)

Unrecognized postretirement benefit obligation during the period

 

85.8

(22.3)

63.5

Amortization of amounts included in net periodic benefit cost (6)

 

36.7

(9.6)

27.1

Net unrecognized postretirement benefit obligation

 

122.5

(31.9)

90.6

Other comprehensive loss

$

(6,249.3)

$

1,340.5

$

(4,908.8)

(1)Pre-tax reclassification adjustments relating to available-for-sale securities are reported in net realized capital gains (losses) and net realized capital gains (losses) on funds withheld assets on the consolidated statements of operations.
(2)See Note 5, Derivative Financial Instruments, under the caption “Effect of Fair Value and Cash Flow Hedges on Consolidated Statements of Operations” for further details.
(3)Includes the discount rate remeasurement gain (loss) associated with the LFPB and the associated reinsurance recoverable. See Note 10, Future Policy Benefits and Claims, under the caption “Liability for Future Policy Benefits” for further details.
(4)See Note 11, Market Risk Benefits, for further details.
(5)Relates to the release of cumulative translation adjustment from the dissolution of foreign subsidiaries.
(6)Amount is comprised of amortization of prior service cost (benefit) and recognized net actuarial (gain) loss, which is reported in operating expenses on the consolidated statements of operations. See Note 15, Employee and Agent Benefits, under the caption “Components of Net Periodic Benefit Cost” for further details.
Accumulated Other Comprehensive Income (Loss) (Table)

MRB

Net unrealized

Net unrealized

LFPB

nonperformance

Foreign

Unrecognized

Accumulated

gains (losses) on

gains (losses)

discount rate

risk

currency

postretirement

other

available-for-sale

on derivative

remeasurement

remeasurement

translation

benefit

comprehensive

   

securities (1)

   

instruments

   

gain (loss)

   

gain (loss)

   

adjustment

   

obligation

   

loss

(in millions)

Balances as of January 1, 2022

$

3,880.4

$

56.6

$

(4,037.6)

$

(90.1)

$

(1,548.7)

$

(344.7)

$

(2,084.1)

Other comprehensive loss during the period, net of adjustments

 

(10,157.9)

(0.9)

4,778.5

114.1

(22.9)

63.5

(5,225.6)

Amounts reclassified from AOCI

 

311.3

(22.2)

27.1

316.2

Other comprehensive loss

 

(9,846.6)

(23.1)

4,778.5

114.1

(22.9)

90.6

(4,909.4)

Adjustment for reinsurance (2)

108.3

6.2

114.5

Balances as of December 31, 2022

(5,857.9)

39.7

740.9

24.0

(1,571.6)

(254.1)

(6,879.0)

Other comprehensive income during the period, net of adjustments

1,565.5

(36.0)

(312.7)

(30.9)

73.0

(14.1)

1,244.8

Amounts reclassified from AOCI

277.6

(5.8)

0.6

16.5

288.9

Other comprehensive income

1,843.1

(41.8)

(312.7)

(30.9)

73.6

2.4

1,533.7

Balances as of December 31, 2023

(4,014.8)

(2.1)

428.2

(6.9)

(1,498.0)

(251.7)

(5,345.3)

Other comprehensive loss during the period, net of adjustments

(790.3)

56.6

1,010.0

(8.1)

(287.9)

15.6

(4.1)

Amounts reclassified from AOCI

112.2

(2.7)

15.1

124.6

Other comprehensive income

(678.1)

53.9

1,010.0

(8.1)

(287.9)

30.7

120.5

Balances as of December 31, 2024

$

(4,692.9)

$

51.8

$

1,438.2

$

(15.0)

$

(1,785.9)

$

(221.0)

$

(5,224.8)

(1)Net unrealized gains (losses) on available-for-sale securities for which an allowance for credit loss has been recorded were $(3.8) million, $(4.3) million and $0.3 million as of December 31, 2024, 2023 and 2022, respectively.
(2)Reflects the January 1, 2022, balance associated with our exited ULSG business that was ceded to an unaffiliated reinsurance company.
Redeemable Noncontrolling Interest (Table)

For the year ended December 31,

   

2024

   

2023

   

2022

 

(in millions)

Beginning balance

$

248.9

$

262.0

$

332.5

Net income (loss) attributable to redeemable noncontrolling interest

11.8

23.7

(25.8)

Redeemable noncontrolling interest of deconsolidated entities (1)

(185.6)

(3.0)

(2.8)

Contributions from redeemable noncontrolling interest

 

330.0

 

43.3

 

67.3

Distributions to redeemable noncontrolling interest

 

(55.8)

 

(75.0)

 

(108.9)

Purchase of subsidiary shares from redeemable noncontrolling interest (2)

 

(0.6)

 

(1.6)

 

(1.1)

Change in redemption value of redeemable noncontrolling interest

 

(4.4)

 

(1.1)

 

(0.2)

Stock-based compensation attributable to redeemable noncontrolling interest

0.2

0.1

0.1

Other comprehensive income (loss) attributable to redeemable noncontrolling interest

 

(6.8)

 

0.5

 

0.9

Ending balance

$

337.7

$

248.9

$

262.0

(1)We deconsolidated certain sponsored investment funds as they no longer met the requirements for consolidation.
(2)In 2024, 2023 and 2022, we acquired an additional interest in Origin Asset Management.